Barclays PLC Grifols Sa Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Grifols Sa stock. As of the latest transaction made, Barclays PLC holds 85,175 shares of GRFS stock, worth $755,502. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,175
Previous 83,418
2.11%
Holding current value
$755,502
Previous $621,000
2.58%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding GRFS
# of Institutions
166Shares Held
153MCall Options Held
76.5KPut Options Held
106K-
Brandes Investment Partners, LP La Jolla, CA25.7MShares$228 Million1.99% of portfolio
-
Capital World Investors Los Angeles, CA21.5MShares$191 Million0.03% of portfolio
-
Permian Investment Partners, LP New York, NY18.1MShares$160 Million23.98% of portfolio
-
Black Creek Investment Management Inc. Toronto, A612.7MShares$113 Million4.37% of portfolio
-
Armistice Capital, LLC New York, NY9.28MShares$82.3 Million1.01% of portfolio
About Grifols SA
- Ticker GRFS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 678,910,976
- Market Cap $6.02B
- Description
- Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...